News
It is playing catch-up with a rival Lp (a) targeting antisense drug from Novartis and development partner Akcea, called pelacarsen, which is already in a phase 3 trial called HORIZON with major ...
Bayer is pressing ahead with a phase 3 trial of its oral Factor XIa inhibitor asundexian, a new anticoagulant, despite missing efficacy targets in two mid-stage studies.
Welcome to the Money blog, Sky News' personal finance and consumer hub. Today: our weekly Cheap Eats feature, in which a top chef tells us his most controversial opinion. And good mortgage news ...
Existing firing schemes for the firing of three-phase SCR bridge rectifiers used for industrial applications employ equidistant firing pulses. Mostly they consist of six identical phase control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results